Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
N/A
-249,657 Reduced 99.68%
801 $1,000
Q4 2022

Feb 13, 2023

SELL
N/A
-264,583 Reduced 51.37%
250,458 $323,000
Q3 2022

Nov 14, 2022

SELL
$1.29 - $2.52 $17,444 - $34,077
-13,523 Reduced 2.56%
515,041 $685,000
Q2 2022

Aug 15, 2022

BUY
$2.22 - $6.7 $255,319 - $770,560
115,009 Added 27.81%
528,564 $1.17 Million
Q1 2022

May 13, 2022

BUY
$4.18 - $13.39 $1.28 Million - $4.12 Million
307,351 Added 289.4%
413,555 $2.56 Million
Q4 2021

Feb 14, 2022

BUY
$11.35 - $97.17 $500,410 - $4.28 Million
44,089 Added 70.98%
106,204 $1.34 Million
Q3 2021

Nov 15, 2021

BUY
$52.0 - $120.21 $1.59 Million - $3.67 Million
30,519 Added 96.59%
62,115 $5.69 Million
Q2 2021

Aug 16, 2021

BUY
$31.88 - $58.66 $1.01 Million - $1.85 Million
31,596 New
31,596 $1.68 Million
Q4 2019

Feb 14, 2020

SELL
$20.77 - $68.91 $1,973 - $6,546
-95 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$19.85 - $45.28 $1,885 - $4,301
95 New
95 $2,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.